ARQIS advises Maki.vc on investment in K Line Europe

14. November 2022

ARQIS has advised the Nordic Seed and Venture Capital Fund Maki.vc regarding a series A financing round of the med tech startup K Line Europe in an amount of 5.3 million euros.

K Line Europe, a dental technology company from Düsseldorf, is providing an eco-friendly alternative to the standard clear aligners that’s both time and money saving for orthodontic patients. K Line Europe produces and exports aligners to the world from a new 3000 sq ft production facility that will transform manufacturing with use of automation, robotics and new innovative products. The company plans to use the new capital to continue its expansion in Europe and enter new markets in Asia, the Middle East and North America.

The ARQIS team around Dr. Lars Laeger advised Maki.vc for the first time. The mandate came about as a result of a recommendation from the market.

 

Advisors to Maki.vc

ARQIS (Düsseldorf): Dr. Lars Laeger (Lead; Corporate/M&A), Johannes Landry (Commercial), Dr. Ulrich Lienhard (Real Estate), Marcus Nothhelfer (IP); Counsel: Thomas Chwalek (Corporate/M&A), Sina Janke (Compliance), Jens Knipping (Tax); Special Counsel: Anja Markworth (Labour Law); Managing Associates: Nora Meyer-Stratmann (IP), Franziska Resch (Corporate/ M&A); Associates: Constanze Eberz (Labour Law), Daniel Schlemann (Data Law), Jasmin Stuckenbrock (Corporate/M&A), Rolf Tichy (IP); Legal Specialists: Maria Fischer (IP), Julia Regenauer (Pensions)

HOW CAN WE HELP YOU?

If you have any questions, please write to us.